Guía práctica de tratamiento urgente de la microangiopatía trombótica-Reference-Cited by-同舟云学术

Guía práctica de tratamiento urgente de la microangiopatía trombótica

Published:2018-08 Issue:3 Volume:151 Page:123.e1-123.e9
ISSN:0025-7753
Container-title:Medicina Clínica
language:es
Short-container-title:Medicina Clínica

Author:

Romero Samuel,Sempere Amparo,Gómez-Seguí Inés,Román Elena,Moret Andrés,Jannone Rosa,Moreno Iván,Mendizábal Santiago,Espí Jordi,Peris Ana,Carbonell Rafael,Cervera José,Pemán Javier,Bonanad Santiago,de la Rubia Javier,Jarque Isidro

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies;Scully;Br J Haematol.,2012

2. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group];Contreras;Med Clin (Barc).,2015

3. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies;Scully;J Thromb Haemost.,2017

4. Thrombotic microangiopathy: A multidisciplinary team approach;Gordon;Am J Kidney Dis.,2017

5. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients;Vesely;Blood.,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments — an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES);Emergencias;2024-07-02

2. Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons;Expert Review of Hematology;2024-02-20

3. Thrombotic microangiopathy secondary to Capnocytophaga canimorsus bacteremia;Iberoamerican Journal of Medicine;2023-11-15

4. Differentiating between severe hypertension and thrombocytopenic purpura as the cause of thrombotic microangiopathy in a patient with Castleman disease: a case report and literature review;Oxford Medical Case Reports;2023-06-01

5. Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura;Expert Review of Hematology;2021-08-03